Concepedia

Antonis D. Tsiailanis

AD

Statistics

Publications

5

Citations

138

H-Index

5

Active since

2017

Affiliations

University of Ioannina(Current)

National and Kapodistrian University of Athens

Hammersmith Hospital

Imperial College London

Antonis D. Tsiailanis is an author at University of Ioannina specializing in pharmacology, medicine, and pharmacotherapy.

Top concepts

Publications per year

2017–2022

5

Publications

5

Encapsulation of Temozolomide in a Calixarene Nanocapsule Improves Its Stability and Enhances Its Therapeutic Efficacy against Glioblastoma

Alexander Renziehausen, Antonis D. Tsiailanis, Richard Perryman et al. · Molecular Cancer Therapeutics · 2019 · 40 citations · Full text

Enhancement of glioblastoma multiforme therapy through a novel Quercetin-Losartan hybrid

Antonis D. Tsiailanis, Alexander Renziehausen, Sofia Kiriakidi et al. · Free Radical Biology and Medicine · 2020 · 30 citations

, , +11

Rational design and structure–activity relationship studies of quercetin–amino acid hybrids targeting the anti-apoptotic protein Bcl-xL

Tahsin F. Kellici, Μaria V. Chatziathanasiadou, Min‐Sung Lee et al. · Organic & Biomolecular Chemistry · 2017 · 28 citations

Inhibition of the angiotensin II type 2 receptor AT <sub>2</sub> R is a novel therapeutic strategy for glioblastoma

Richard Perryman, Alexander Renziehausen, Hamidreza Shaye et al. · Proceedings of the National Academy of Sciences · 2022 · 24 citations · Full text

Tailoring naringenin conjugates with amplified and triple antiplatelet activity profile: Rational design, synthesis, human plasma stability and in vitro evaluation

Evgenios Κ. Stylos, Μaria V. Chatziathanasiadou, Antonis D. Tsiailanis et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 2017 · 16 citations

, , +10

1–5 of 5